Parametrica Management LTD Instil Bio, Inc. Transaction History

Parametrica Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$4.65 - $7.37 $3,441 - $5,453	740 Added 0.85%	88,263 $428,000
Q2 2022 Jul 22, 2022	BUY	$4.21 - $11.15 $368,471 - $975,881	87,523 New	87,523 $402,000
Q1 2022 May 10, 2022	SELL	$8.48 - $18.1 $429,927 - $917,651	-50,699 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$15.37 - $22.5 $68,765 - $100,665	4,474 Added 9.68%	50,699 $867,000
Q3 2021 Nov 12, 2021	BUY	$15.05 - $23.28 $695,686 - $1.08 Million	46,225 New	46,225 $826,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.